For laboratory research only
Compare AOD-9604 research suppliers
Listings now default to lowest tracked price per mg. The highlighted price badge is a catalog-price signal only, not a quality, safety, or documentation ranking.
The document count covers six basic checks. “Not found” means we could not confirm it from the public records we reviewed—not that the testing never happened.
Affiliate disclosure: Some links may earn PDD a commission. Affiliate status does not change what we report or how suppliers are ordered.
PS Peptides
5 of 6 fields documentedPossibly outdatedAOD-9604 (5 mg)
Exact name catalog match · Affiliate relationship · Price badge is not an overall recommendation
Listed price
$39.99
$8.00 per mg
Est. with PDD10: $35.99
$7.20/mg
In stock
Elite Research Labs
6 of 6 fields documentedChecked 12 days agoAOD-9604 (5 mg)
Exact name catalog match · Affiliate relationship
Listed price
$42.49
$8.50 per mg
In stock
Particle Peptides
2 of 6 fields documentedReview recommendedAOD-9604 (5 mg)
Exact name catalog match · Affiliate relationship · Price badge is not an overall recommendation
Listed price
€44.71
€8.94 per mg
In stock
True Peptides
1 of 6 fields documentedPossibly outdatedAOD-9604 (5 mg)
Exact name catalog match · Affiliate relationship
Listed price
$45.00
$9.00 per mg
In stock
Offline Peptides
2 of 6 fields documentedReview recommendedAOD-9604 (5 mg)
Exact name catalog match · Affiliate relationship
Listed price
$49.00
$9.80 per mg
In stock
How AOD-9604 is used in research
AOD-9604 was designed to isolate selected metabolic actions associated with a region of growth hormone without reproducing the full hormone’s activity profile.
Published work includes cell and animal models examining lipid metabolism and cartilage-related endpoints, as well as early clinical development in obesity research.
Evidence map
Research stage matters. Findings from one model should not be silently promoted to another.
Laboratory
Cell and tissue studies have examined metabolic and cartilage-related signaling.
Animal
Preclinical models have evaluated body-composition and joint-tissue endpoints.
Human
Early clinical research was conducted, but the molecule is not an FDA-approved drug.
What the evidence does not establish
The evidence base is heterogeneous, and findings from metabolic or cartilage models do not establish clinical benefit, safety, or suitability for personal use.
Study findings also do not authenticate a supplier’s material. Biological plausibility, a familiar name, or a published paper cannot substitute for lot-specific identity and quality evidence.
Analytical and documentation checks
The test plan should match the exact molecule, modification, and research question.
- Confirm the exact modified sequence and terminal chemistry.
- Do not treat an HPLC area result as proof of peptide content by mass.
- Match identity and purity reports to the current lot.
At minimum, connect the product name, sequence, sample identifier, lot, report, method, expected result, and observed result. Record untested attributes as “not reported,” not as assumed passes.
Build the documentation record
Regulatory status
AOD-9604 is not an FDA-approved drug. Research activity and appearance in a commercial catalog do not confer approval.
Regulatory status can change and attaches to specific products and jurisdictions. Verify current official records before publishing, procuring, or relying on a status claim.
Primary sources and official records
Use these records as starting points, then assess the exact model, test article, methods, and date:
Peptide Due Diligence Research Brief
Follow the evidence, not the headline.
Receive new evidence maps, documentation guides, and material corrections as the directory expands.
By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.
Already subscribed? Get your free checklist.